Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,691,826 |
|
|||||
| News | - | ||||||
| Day High | 10.59 | Low High |
|||||
| Day Low | 10.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vir Biotechnology Inc | VIR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.12 | 12.20% | 10.30 | 18:29:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.00 | 10.00 | 10.59 | 10.39 | 9.18 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,282 | 1,691,826 | $ 10.30 | $ 17,434,186 | - | 7.61 - 27.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:21:46 | 5 | $ 10.42 | USD |
Vir Biotechnology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.4B | 135.03M | - | 86.18M | -615.06M | -4.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vir Biotechnology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VIR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.74 | 10.59 | 7.64 | 8.63 | 1,116,549 | 2.56 | 33.07% |
| 1 Month | 9.29 | 10.59 | 7.61 | 8.54 | 880,459 | 1.01 | 10.87% |
| 3 Months | 9.30 | 12.00 | 7.61 | 9.95 | 1,036,498 | 1.00 | 10.75% |
| 6 Months | 8.33 | 12.00 | 7.61 | 9.73 | 1,121,171 | 1.97 | 23.65% |
| 1 Year | 24.73 | 27.48 | 7.61 | 12.52 | 1,193,919 | -14.43 | -58.35% |
| 3 Years | 48.22 | 58.00 | 7.61 | 24.90 | 1,150,583 | -37.92 | -78.64% |
| 5 Years | 16.15 | 141.01 | 7.61 | 30.60 | 1,128,045 | -5.85 | -36.22% |
Vir Biotechnology Description
| Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue. |
